Building Africa's Reference Platform for Genomic and Immune Data
Ethically sourced African genomic, immune, and health data for precision medicine, drug discovery, and AI.
Why UloGenes Exists
Africa contains the greatest genetic diversity on Earth, yet remains dramatically underrepresented in genomic research. This gap limits scientific discovery, precision medicine, and equitable healthcare innovation.
UloGenes was founded to change that reality.
Less than 2% of the genomic data in global databases comes from African populations — even though the continent holds the greatest human genetic diversity on Earth.
The result: weaker drug discovery, narrower disease understanding, less accurate precision medicine, and missed opportunities for Africa and the world.
Why Nigeria?
Nigeria's population diversity and size make it an ideal place to begin building a representative African genomic resource.
Why Africa?
African populations have the highest genetic diversity, critical for advancing global health equity and scientific discovery.
Why Now?
Advances in sequencing, immunology, and AI make it possible to build the infrastructure that didn't exist before.
How We Start
We are executing a focused, first step pilot study to build a world-class resource with global impact in biotech, pharma, AI healthcare, ancestry, and academic research.
Sent to Legal@Ulogenes.com — we reply with the pilot brief and next steps.
Why UloGenes Is Different
UloGenes is not simply sequencing genomes; we are building ethically governed African reference biodata linked to genomics, immune profiles, ancestry, and health metadata.
Targeted Impact
Healthcare
Enable better disease understanding and precision medicine for all populations.
Drug Discovery
Improve target identification and accelerate development of effective therapies.
AI & Innovation
Develop high-quality, diverse datasets to train the next generation of biomedical AI.
Population Science
Advance our understanding of human diversity, ancestry, and evolutionary health insights.
Leadership
Advisors
Nigerian Partners
Ethics & Governance
UloGenes is built on responsible research, local oversight, and participant trust. Before each study, we obtain all required national, state, and institutional ethics committee approvals.
Our governance model includes clear participant consent, qualified local principal collaborators, and approved rights to responsibly share de-identified data for research and partnership use.
- Ethics approvals before each study
- Clear and concise participant consent
- Local qualified principal collaborators
- Approved rights to share de-identified data
- Protection of participant privacy and confidentiality
Partner With UloGenes
We are opening early conversations with organizations whose work depends on high-quality, ethically sourced African biodata.
Biotech & Pharma
Improve target discovery, biomarker validation, and clinical trial design with representative African data.
AI & Healthcare
License diverse, well-phenotyped reference datasets to train and validate biomedical AI models.
Academic Research
Collaborate on studies in genomics, immunology, infectious disease, and population health.
Ancestry & Lineage
Access reference panels for accurate ancestry inference across African populations.
For qualified research, clinical, and commercial partners. For the pilot study brief, use the request button above.
Join us in building the future of African genomics.
Investors, advisors, researchers, and partners — we'd like to hear from you.